𝔖 Bobbio Scriptorium
✦   LIBER   ✦

W1394 Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Patients with Pancreatic Cancer

✍ Scribed by Uyama, Hirokazu; Nakamura, Hideji

Book ID
123073399
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
54 KB
Volume
134
Category
Article
ISSN
0016-5085

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatoma-derived growth factor is a nove
Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors
✍ Kuo-Chin Chang; Ming-Hong Tai; Jui-Wei Lin; Chih-Chi Wang; Chao-Cheng Huang; Cha πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 335 KB

## Abstract Proliferating activity as mitotic count is generally accepted as a major prognostic indicator for gastrointestinal stromal tumors (GISTs). Hepatoma‐derived growth factor (HDGF) is a novel growth factor and elevated in several types of cancer. Our study was designed to elucidate the expr

Nuclear expression of epidermal growth f
Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer
✍ Weiya Xia; Yongkun Wei; Yi Du; Jinsong Liu; Bin Chang; Yung-Luen Yu; Long-Fei Hu πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 328 KB πŸ‘ 1 views

## Abstract The epidermal growth factor receptor (EGFR) has previously been detected in the nucleus of cancer cells and primary tumors. We have reported that EGFR translocates from the plasma membrane to the nucleus. Accumulation of nuclear EGFR is linked to increased DNA synthesis and proliferatio